MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, VNDA made $51,718K in revenue. -$48,567K in net income. Net profit margin of -93.91%.

Income Overview

Revenue
$51,718K
Net Income
-$48,567K
Net Profit Margin
-93.91%
EPS
-$0.82
Unit: Thousand (K) dollars
Revenue Breakdown
    • Fanapt
    • Hetlioz
    • PONVORY

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
51,718 57,216 56,258 52,590
Cost of goods sold excluding amortization
3,159 3,833 2,954 2,736
Research and development
28,435 29,006 22,563 21,990
Selling, general and administrative
68,361 62,978 60,273 64,616
Intangible asset amortization
1,987 1,752 1,752 1,751
Total operating expenses
101,942 97,569 87,542 91,093
Loss from operations
-50,224 -40,353 -31,284 -38,503
Other income, net
1,800 2,351 2,894 3,616
Loss before income taxes
-48,424 -38,002 -28,390 -34,887
Provision (benefit) for income taxes
143 103,185 -5,804 -7,680
Net loss
-48,567 -141,187 -22,586 -27,207
Basic EPS
-0.82 -2.389 -0.38 -0.46
Diluted EPS
-0.82 -2.389 -0.38 -0.46
Basic Average Shares
59,459,982 59,107,385 59,091,478 58,993,990
Diluted Average Shares
59,459,982 59,107,385 59,091,478 58,993,990
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$48,567K (-64.67%↓ Y/Y)Fanapt$29,560K Hetlioz$15,947K PONVORY$6,211K Loss before incometaxes-$48,424K (-29.59%↓ Y/Y)Provision (benefit) forincome taxes$143K (101.82%↑ Y/Y)Other income, net$1,800K (-50.82%↓ Y/Y)net product sales$51,718K (3.35%↑ Y/Y)Loss from operations-$50,224K (-22.41%↓ Y/Y)Total revenues$51,718K (3.35%↑ Y/Y)Total operatingexpenses$101,942K (11.94%↑ Y/Y)Selling, general andadministrative$68,361K (36.49%↑ Y/Y)Research and development$28,435K (-20.38%↓ Y/Y)Cost of goods soldexcluding amortization$3,159K (-10.28%↓ Y/Y)Intangible assetamortization$1,987K (13.41%↑ Y/Y)

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA)